Validation of Self Report Version of the Leeds Assessment of Neuropathic Symptoms and Signs Score for Identification of Neuropathic Pain in Patients from Northern Turkey

Basit Öğe Kaydı
dc.contributor.authorTurkel, Yakup
dc.contributor.authorTurker, Hande
dc.contributor.authorDemir, Ilknur A.
dc.contributor.authorBayrak, Ayse O.
dc.contributor.authorOnar, Musa K.
dc.date.accessioned2020-06-25T18:12:10Z
dc.date.available2020-06-25T18:12:10Z
dc.date.issued2014
dc.departmentKırıkkale Üniversitesi
dc.description.abstractBackground. Diagnosis and treatment of neuropathic pain is an important clinical problem. Objectives. A self report version of the Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score provides identification of neuropathic pain without the help and need of a clinician. We targeted validation of the S-LANSS score in the nothern Turkish population in this study. Material and Methods. For the linguistic validation of S-LANSS, translation and back-translation method was used to adapt S-LANSS into Turkish and a cognitive-debriefing test was performed. A total of 148 patients were enrolled in the present study. S-LANSS, The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), Visual Annalogue Score (VAS) and Neuropathic Pain Questionnaire (NPQ) were performed twice for every patient. The patients were examined and diagnosed as having nociceptive or neuropathic pain by neurologists, who were blind for S-LANSS, LANSS and NPQ scores of the patients. Results. Results of the McNemar test indicated that S-LANSS scores were reliable when the first and the second scores were compared. The sensitivity and specificity of the scale were found to be 98% and 97% respectively. Conclusions. We believe that using S-LANSS scores for the diagnosis of neuropathic pain may help our colleagues as a tool for a quicker differential diagnosis of pain in daily practice.en_US
dc.description.sponsorshipPfizer Pharmaceutical CompanyPfizeren_US
dc.description.sponsorshipThis study was supported by Pfizer Pharmaceutical Company.en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.endpage603en_US
dc.identifier.issn1899-5276
dc.identifier.issue4en_US
dc.identifier.pmid25166445
dc.identifier.scopus2-s2.0-84909600063
dc.identifier.scopusqualityQ1
dc.identifier.startpage599en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12587/5778
dc.identifier.volume23en_US
dc.identifier.wosWOS:000344634400014
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWroclaw Medical Univen_US
dc.relation.ispartofAdvances In Clinical And Experimental Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectS-LANSSen_US
dc.subjectneuropathic painen_US
dc.subjectvalidationen_US
dc.titleValidation of Self Report Version of the Leeds Assessment of Neuropathic Symptoms and Signs Score for Identification of Neuropathic Pain in Patients from Northern Turkeyen_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Validation of Self Report Version of the Leeds Assessment of Neuropathic Symptoms and Signs Score for Identification of Neuropathic Pain in Patients from Northern Turkey.pdf
Boyut:
53.53 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu